latest update:
[RxAtlas]

drug summary · 2 NDC codes

BRIXADI 64 mg/.18mL

BUPRENORPHINE

HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status NDA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.

dataset id 55755NDC codes 2application NDA210136RxCUI —

Facts

Field definitions, types, and provenance rules are in the data dictionary.

generic nameBUPRENORPHINE
active ingredientsBUPRENORPHINE
dosage formINJECTION
routeSUBCUTANEOUS
strength64 mg/.18mL
marketing statusNDA
DEA scheduleCIII
application numberNDA210136
ATC codenot reported
RxCUInot reported
manufacturerBraeburn Inc.
product typeHUMAN PRESCRIPTION DRUG
pharmacologic classPartial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]

NDC codes

2 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.

NDCPackage description
58284-264—
58284026401—

Other BUPRENORPHINE products

6 other products in the current release publish the same generic name. Strength, dosage form, and labeler are what distinguish them.

Work with this record

  • Field definitions

    Types, scope, and provenance rules for every exported field.

  • REST API

    Query the same gate-backed records programmatically.

  • Evaluation sample

    Download a bounded slice before buying.

  • $29 API Pass

    Seven days of REST and MCP access to the full catalogue; credited toward the licence.